PKD1 and prostate cancer: For example, direct interaction and phosphorylation of E-cadherin by PKD1 in adherent junctional sites resulted in increased cell aggregation and decreased cell motility in non-invasive LNCaP prostate cancer cells (Du et al., 2009).